Physician
Center for Pain Management, LLC
Center for Pain Management, LLC was paid $18.80M by Medicaid between Jan 2018 and Dec 2024, across 45 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 88% of everything it billed.
33Billing provider infoCENTER FOR PAIN MANAGEMENT, LLC
HAGERSTOWN, MD 21740
HAGERSTOWN, MD 21740
33aNPI1962463265assigned 03/28/2006
33bProvider typeInterventional Pain Medicine Physician
28Total paid$18.80M
24GClaims295,347
24DCodes billed45
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Interventional Pain Medicine Physician providers in Maryland
Rank by total paid#1 of 8
Median peer was paid$148K
This provider vs. median127×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official TINCH, SHANEKA controls 16+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 30,155 | $2.67M | |
| 2019 | 33,321 | $2.05M | |
| 2020 | 61,818 | $3.06M | |
| 2021 | 49,197 | $3.12M | |
| 2022 | 48,862 | $3.12M | |
| 2023 | 40,467 | $2.75M | |
| 2024incomplete | 31,527 | $2.03M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 88% | 237,663 | 188,904 | $16.55M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.2% | 21,621 | 17,616 | $974K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.4% | 3,479 | 2,967 | $267K |
| 99205 | Prolong outpt/office vis | 1.0% | 1,316 | 1,014 | $194K |
| 64483 | <1% | 4,843 | 3,137 | $151K | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 1,017 | 799 | $113K |
| 62323 | <1% | 1,784 | 1,230 | $85K | |
| 77002 | <1% | 3,451 | 2,192 | $70K | |
| 62321 | <1% | 1,110 | 703 | $63K | |
| 20610 | <1% | 4,215 | 2,647 | $60K | |
| 64636 | <1% | 1,517 | 1,049 | $51K | |
| 64494 | <1% | 1,968 | 1,375 | $37K |
33 more codes
| 64484 | <1% | 1,476 | $26K | |
| 64495 | <1% | 1,021 | $25K | |
| 20611 | <1% | 579 | $22K | |
| 99245 | <1% | 81 | $17K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,058 | $12K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 345 | $11K |
| 64635 | <1% | 1,574 | $11K | |
| 64493 | <1% | 2,053 | $11K | |
| 01936 | <1% | 394 | $11K | |
| 27096 | <1% | 357 | $8K | |
| 99441 | <1% | 457 | $6K | |
| L0650 | Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf | <1% | 42 | $5K |
| 76942 | <1% | 76 | $4K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 286 | $3K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 269 | $3K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 12 | $2K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 29 | $2K |
| 99442 | <1% | 140 | $2K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 363 | $1K |
| 64491 | <1% | 29 | $992.26 | |
| 20553 | <1% | 30 | $688.45 | |
| 64490 | <1% | 59 | $506.09 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 18 | $407.04 |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | <1% | 81 | $100.18 |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 25 | $69.30 |
| 99497 | <1% | 12 | $56.12 | |
| 80305 | <1% | 223 | $53.27 | |
| J1020 | Injection, methylprednisolone acetate, 20 mg | <1% | 14 | $46.54 |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | <1% | 122 | $40.16 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 73 | $11.63 |
| G8907 | Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer or hospital admission upon discharge from the facility | 0% | 12 | $0.00 |
| G8918 | Patient without preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis | 0% | 12 | $0.00 |
| 64633 | 0% | 41 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTINCH, SHANEKA (RCM MANAGER)
| Provider | Location | Paid |
|---|---|---|
| Interventional Pain Center PLLC | Fayetteville, NC | $6.14M |
| Physical Medicine Associates, LTD | Mc Lean, VA | $1.79M |
| Asc Development Company, LLC | Hagerstown, MD | $113K |
| Asc Development Company, LLC | Frederick, MD | $42K |
| Asc Development Company, LLC | Germantown, MD | $31K |
| Florida Pain and Rehabilitation Associates INC | Delray Beach, FL | $25K |
| Asc Development Company, LLC | Pikesville, MD | $24K |
| Asc Development Company, LLC | Glen Burnie, MD | $24K |
| Center for Pain Management, LLC | Columbia, MD | $15K |
| Asc Development Company LLC | White Plains, MD | $14K |
| Asc Development Company, LLC | Bel Air, MD | $7K |
| NSPC Surgery Center of Maryland LLC | Oxon Hill, MD | $6K |
| National Surgical Centers of America LLC | Winter Park, FL | $2K |
| Florida Pain and Rehabilitation Associates INC | Delray Beach, FL | $377.09 |
| Physical Medicine Associates LTD | Oxon Hill, MD | $0.00 |
| Pain Consultants Asc LLC | Pascagoula, MS | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.